Can we be SMaRT-er in our approach to cancer therapy? - Wikidata - wikimedia - TriplyDB

Can we be SMaRT-er in our approach to cancer therapy?

Can we be SMaRT-er in our approach to cancer therapy?

http://www.wikidata.org/entity/Q42491454

about

Can we be SMaRT-er in our approach to cancer therapy?

http://www.wikidata.org/entity/Q42491454

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Can we be SMaRT-er in our approach to cancer therapy?

@en

Can we be SMaRT-er in our approach to cancer therapy?

@nl

type

label

Can we be SMaRT-er in our approach to cancer therapy?

@en

Can we be SMaRT-er in our approach to cancer therapy?

@nl

prefLabel

Can we be SMaRT-er in our approach to cancer therapy?

@en

Can we be SMaRT-er in our approach to cancer therapy?

@nl

P1433

Q42491454-3249D7C4-2F63-4096-BE45-1FE5ACF3050D

P1476

Q42491454-1E38652F-CC65-4EA9-A786-7EE6DD9F4276

P2093

Q42491454-2C20C783-26EA-4D6A-9ECF-FAB14FC51E23

Q42491454-8A6D8F4D-964C-442F-B701-B0CA41A01251

Q42491454-E8A4E4E1-A4A1-47A1-B169-3245C5746E2F

P2860

Q42491454-355C6474-1943-45D6-AB74-CBDDE0A52354

Q42491454-3740D410-2A88-4D5D-AB25-A5C6CF417071

Q42491454-5D2B1C93-8514-4C94-A4EC-757B6AFD3A99

Q42491454-74D8E2CB-FDC6-49A0-A928-0842D5930313

Q42491454-7BB487F1-2135-406A-9A0D-FBF4FB82A958

Q42491454-7F106B44-FC06-4C70-9A6A-C5233167B0DF

Q42491454-9EDDEC86-D749-4F92-BC42-7E04F8326164

Q42491454-A59CB5A0-0B9B-4F9F-A3D1-C3691737CD6D

Q42491454-DD008382-403D-4E02-9150-4D6F3BB69C2B

Q42491454-FDC41093-A5E4-4905-8128-CAA3969D6452

P304

Q42491454-E07E7287-5522-41E5-97E0-5E25CDF7FEF4

P31

Q42491454-287BBB03-0EEF-49DA-8F40-8FF9F682BEEF

P356

Q42491454-820090F4-4BA0-42C6-9E0C-347C5931534E

P433

Q42491454-DDE305ED-E28B-4DF5-9086-3BB3EEF98E7E

P478

Q42491454-A50DD5AD-5FAB-4147-AF1D-1DC4EDA3B4BE

P577

Q42491454-79FD30BC-7752-4A55-ACD9-243BD7CF385A

P5875

Q42491454-20D8B8BF-D4DD-4CFF-A0B0-4C5B9404EA7F

P698

Q42491454-0DCD20F6-F2EB-408A-80F4-0FEF71ACE2FD

P932

Q42491454-0C105F1A-2564-488B-86D1-718CA46E4DBC

P356

J.EBIOM.2015.06.002

P1433

P1476

Can we be SMaRT-er in our approach to cancer therapy?

@en

P2093

Christina Gruber

http://www.w3.org/2001/XMLSchema#string

Johann W Bauer

http://www.w3.org/2001/XMLSchema#string

Josefina Piñón Hofbauer

http://www.w3.org/2001/XMLSchema#string

P2860

Spliceosome-mediated trans-splicing: the therapeutic cut and paste

CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia

Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo.

CD22ΔE12 as a molecular target for corrective repair using RNA trans-splicing: anti-leukemic activity of a rationally designed RNA trans-splicing molecule

Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL.

Trans-splicing improvement by the combined application of antisense strategies.

Cis-splicing and translation of the pre-trans-splicing molecule combine with efficiency in spliceosome-mediated RNA trans-splicing

The design and optimization of RNA trans-splicing molecules for skin cancer therapy.

Spliceosome-mediated RNA trans-splicing as a tool for gene therapy.

Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing.

P304

621-622

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EBIOM.2015.06.002

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277959670

http://www.w3.org/2001/XMLSchema#string

P698

26288827

http://www.w3.org/2001/XMLSchema#string

P932

4534698

http://www.w3.org/2001/XMLSchema#string